KemPharm (KMPH) Misses Q2 EPS by 56c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
KemPharm Reports Second Quarter 2022 Financial Results and Corporate Updates
August 11, 2022 4:05 PM EDTConference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, August 11, 2022, at 5:00 p.m. ET
Perry Sternberg, Corium, Inc.s President and CEO, to Participate and Provide Update on the Commercialization of AZSTARYS®
Acquired substantially all the assets and operations of Orphazyme A/S, including arimoclomol, for a cash payment of $12.8 millionResubmission of the arimoclomol NDA for the treatment of NPC as early as Q1 2023Filed IND application for KP1077,... More